|
1
|
GLOBOCAN: Estimated Cancer Incidence,
Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Default.aspx.
Access date: June 10, 2016.
|
|
2
|
Rodin D, Knaul FM, Lui TY and
Gospodarowicz M: Radiotherapy for breast cancer: The predictable
consequences of an unmet need. Breast. 29:120–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fisher B, Anderson S, Bryant J, Margolese
RG, Deutsch M, Fisher ER, Jeong JH and Wolmark N: Twenty-year
follow-up of a randomized trial comparing total mastectomy,
lumpectomy, and lumpectomy plus irradiation for the treatment of
invasive breast cancer. N Engl J Med. 347:1233–1241. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim JJ and Tannock IF: Repopulation of
cancer cells during therapy: An important cause of treatment
failure. Nat Rev Cancer. 5:516–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peitzsch C, Kurth I, Kunz-Schughart L,
Baumann M and Dubrovska A: Discovery of the cancer stem cell
related determinants of radioresistance. Radiother Oncol.
108:378–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luckey TD: physiological benefits from low
levels of ionizing radiation. Health Phys. 43:771–789. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feinendegen LE: Evidence for beneficial
low level radiation effects and radiation hormesis. Br J Radiol.
78:3–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olivieri G, Bodycote J and Wolff S:
Adaptive response of human lymphocytes to low concentrations of
radioactive thymidine. Science. 223:594–597. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li W, Wang G, Cui J, Xue L and Cai L:
Low-dose radiation (LDR) induces hematopoietic hormesis:
LDR-induced mobilization of hematopoietic progenitor cells into
peripheral blood circulation. Exp Hematol. 32:1088–1096. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang X, So YH, Cui J, Ma K, Xu X, Zhao Y,
Cai L and Li W: The low-dose ionizing radiation stimulates cell
proliferation via activation of the MAPK/ERK pathway in rat
cultured mesenchymal stem cells. J Radiat Res (Tokyo). 52:380–386.
2011. View Article : Google Scholar
|
|
11
|
Jiang H, Xu Y, Li W, Ma K, Cai L and Wang
G: Low-dose radiation does not induce proliferation in tumor cells
in vitro and in vivo. Radiat Res. 170:477–487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee CL, Blum JM and Kirsch DG: Role of p53
in regulating tissue response to radiation by mechanisms
independent of apoptosis. Transl Cancer Res. 2:412–421. 2013.
|
|
13
|
Menon V and Povirk L: Involvement of p53
in the repair of DNA double strand breaks: Multifaceted roles of
p53 in homologous recombination repair (HRR) and non-homologous end
joining (NHEJ). Subcell Biochem. 85:321–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Freed-Pastor WA and Prives C: Mutant p53:
One name, many proteins. Genes Dev. 26:1268–1286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JS, Lee C, Bonifant CL, Ressom H and
Waldman T: Activation of p53-dependent growth suppression in human
cells by mutations in PTEN or PIK3CA. Mol Cell Biol. 27:662–677.
2007. View Article : Google Scholar :
|
|
16
|
Zhang H, Zeitz MJ, Wang H, Niu B, Ge S, Li
W, Cui J, Wang G, Qian G, Higgins MJ, et al: Long noncoding
RNA-mediated intrachromosomal interactions promote imprinting at
the Kcnq1 locus. J Cell Biol. 204:61–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lindell B and Sowby D: The 1958 UNSCEAR
report. J Radiol Prot. 28:277–282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kadhim M, Salomaa S, Wright E, Hildebrandt
G, Belyakov OV, Prise KM and Little MP: Non-targeted effects of
ionising radiation - implications for low dose risk. Mutat Res.
752:84–98. 2013. View Article : Google Scholar
|
|
19
|
Stankevicins L, Almeida da Silva AP,
Ventura Dos Passos F, Dos Santos Ferreira E, Menks Ribeiro MC, G
David M, J Pires E, Ferreira-Machado SC, Vassetzky Y, de Almeida
CE, et al: MiR-34a is up-regulated in response to low dose, low
energy X-ray induced DNA damage in breast cells. Radiat Oncol.
8:2312013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lehrer S and Rosenzweig KE: Lung cancer
hormesis in high impact states where nuclear testing occurred. Clin
Lung Cancer. 16:152–155. 2015. View Article : Google Scholar
|
|
21
|
Dobrzynski L, Fornalski KW and Feinendegen
LE: Cancer mortality among people living in areas with various
levels of natural background radiation. Dose Response.
13:15593258155923912015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mettler FA, Sinclair WK, Anspaugh L,
Edington C, Harley JH, Ricks RC, Selby PB, Webster EW and Wyckoff
HO: The 1986 and 1988 UNSCEAR (United nations Scientific Committee
on the Effects of Atomic Radiation) reports: Findings and
implications. Health Phys. 58:241–250. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang G, Li W, Jiang H, Liang X, Zhao Y, Yu
D, Zhou L, Wang G, Tian H, Han F, et al: Low-dose radiation may be
a novel approach to enhance the effectiveness of cancer
therapeutics. Int J Cancer. 139:2157–2168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu SZ: On radiation hormesis expressed in
the immune system. Crit Rev Toxicol. 33:431–441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bartek J, Iggo R, Gannon J and Lane DP:
Genetic and immunochemical analysis of mutant p53 in human breast
cancer cell lines. Oncogene. 5:893–899. 1990.PubMed/NCBI
|
|
26
|
Cadwell C and Zambetti GP: The effects of
wild-type p53 tumor suppressor activity and mutant p53
gain-of-function on cell growth. Gene. 277:15–30. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shaulsky G, Goldfinger N and Rotter V:
Alterations in tumor development in vivo mediated by expression of
wild type or mutant p53 proteins. Cancer Res. 51:5232–5237.
1991.PubMed/NCBI
|
|
28
|
Dittmer D, Pati S, Zambetti G, Chu S,
Teresky AK, Moore M, Finlay C and Levine AJ: Gain of function
mutations in p53. Nat Genet. 4:42–46. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yan W, Zhang Y, Zhang J, Liu S, Cho SJ and
Chen X: Mutant p53 protein is targeted by arsenic for degradation
and plays a role in arsenic-mediated growth suppression. J Biol
Chem. 286:17478–17486. 2011. View Article : Google Scholar : PubMed/NCBI
|
